Clinical Trial Update: Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab. [Phase 2, Phase 3]

View source ↗

Summary

Long-term extension study of tildrakizumab in psoriatic arthritis to evaluate safety in participants who previously completed tildrakizumab trials; results have…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Tildrakizumab (tildrakizumab)

Snippet

Sponsor: Sun Pharmaceutical Industries Limited | Conditions: Psoriatic Arthritis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-11-21